New technologies and techniques for prostate cancer focal therapy.

Author: BiancoFernando, CarneiroArie, Castro-AlfaroAdalberto, CathelineauXavier, Linares-EspinósEstefanía, Martínez-SalamancaJuan I, Sanchez-SalasRafael, ValerioMassimo

Paper Details 
Original Abstract of the Article :
INTRODUCTION: The aim of this study was to review the oncological and functional outcomes of new and established primary focal treatments (FT) for localized prostate cancer (PCa). EVIDENCE ACQUISITION: We performed a systematic search of published studies on FT for localized PCa using electronic da...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.23736/S0393-2249.18.03094-1

データ提供:米国国立医学図書館(NLM)

New Technologies and Techniques for Prostate Cancer Focal Therapy

This research delves into the field of prostate cancer treatment, specifically focusing on focal therapy (FT) for localized prostate cancer (PCa). This research area is crucial as it seeks to minimize side effects and improve the quality of life for patients. The study systematically reviewed published data on FT techniques, including hemi-ablation, focal ablation, and target-ablation. The authors analyzed 20 studies involving 2523 patients and examined the oncologic and functional outcomes of various energy sources used for FT. The findings highlight the potential of FT as a promising treatment option for localized PCa.

Encouraging Oncologic and Functional Outcomes of Focal Therapy

This study analyzed a considerable number of patients treated with various FT techniques. The results show that focal therapy can achieve encouraging oncologic outcomes while preserving sexual and urinary functions. While the median follow-up periods varied, the data consistently demonstrated positive results for patient outcomes. The overall post-treatment positive biopsy rate ranged from 1.2% to 51%, with 1.6% to 32% of patients having residual disease in the treated area. This indicates that FT is a viable option for controlling tumor growth while minimizing the impact on patients' quality of life.

Potential for Improved Prostate Cancer Management

The promising results of this study suggest that FT could offer a less invasive and more patient-centered approach to treating localized PCa. This could lead to improved quality of life for patients, reducing the burden of side effects commonly associated with traditional treatments. However, careful patient selection and vigilant follow-up remain crucial for maximizing the benefits of FT. The study emphasizes the importance of selecting appropriate patients and monitoring their progress closely. It's like finding a hidden oasis in the vast desert of treatment options for prostate cancer.

Dr. Camel's Conclusion

Focal therapy is a promising approach for treating localized prostate cancer that deserves further investigation. It could potentially revolutionize the way we manage this disease, providing a more personalized and less invasive treatment option for patients. With careful selection and monitoring, FT could offer a brighter future for those facing prostate cancer.

Date :
  1. Date Completed 2018-11-07
  2. Date Revised 2018-11-07
Further Info :

Pubmed ID

29664243

DOI: Digital Object Identifier

10.23736/S0393-2249.18.03094-1

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.